SEC Form 4 · accession 0001213900-16-014223
Icagen, Inc. · ICGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent Palmieri
Director
Period of report
Jun 10, 2016
Accepted (ET)
Jun 14, 2016 · 8:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001518520
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF1 | $3.50 | Jun 10, 2016 | A | 7,500 | A | Jun 10, 2016 | Jun 9, 2021 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1The warrants were issued to the reporting person by Icagen, Inc. (the "Company") in a private placement offering of units (the "Units" and each a "Unit") with each Unit including a five year warrant to purchase 1,500 shares of the Company's common stock for each $10,000 investment.